Updated:
CTI BIOPHARMA CORP
CTI BIOPHARMA CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000891293, and its reported industry is...
Overview
CTI BIOPHARMA CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000891293, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-06, it reported annual revenue of USD 53,948,000; net income of USD -92,992,000; total assets of USD 125,925,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- CTI BIOPHARMA CORP
- Former names in filing history
- CELL THERAPEUTICS INC (1996-06-28 to 2014-05-29)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Seattle, WA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000891293
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $53.9M | -$93.0M | $125.9M | $30.4M | -$81.2M | |
| FY2021USD | — | -$97.9M | $72.4M | $65.4M | -$84.9M | |
| FY2020USD | $0 | -$52.5M | $58.2M | $40.4M | -$42.2M | |
| FY2019USD | $3.3M | -$40.0M | $46.3M | $31.1M | -$27.8M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| SC 13G | — | Form SC 13G | |
| SC 13G | — | Form SC 13G | |
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research CTI BIOPHARMA CORP in Altss
Track this company’s investors, transactions and relationships in Altss.